Search

Purpose: The primary purpose of this study was to evaluate the accuracy of an MR-thermometry sequence for monitoring prostate temperature. The secondary purposes were to analyze clinical and technical factors that may affect accuracy and testing the method in a realistic setting, with MR-guided Laser ablation on an ex vivo muscle sample., Materials and Methods: An ex vivo muscle sample was subjected to Laser ablation while using a two-dimensional multislice segmented echo planar imaging sequence for MR thermometry. The MR thermometry measurements were compared with invasive sensor temperature readings to assess accuracy. Subsequently, 56 men with a median age of 70 years (age range: 53-84 years) who underwent prostate MRI examinations at 1.5- (n = 27) or 3 T (n = 24) were prospectively included. For each patient, the proportion of 'noisy voxels' (i.e., those with a temporal standard deviation of temperature [SD(T)] > 2 °C) in the prostate was calculated. The impact of clinical and technical factors on the proportion of noisy voxels was also examined., Results: MR-thermometry showed excellent correlation with invasive sensors during MR-guided Laser ablation on the ex vivo muscle sample. The median proportion of noisy voxels per patient in the entire cohort was 1 % (Q1, 0.2; Q3, 4.9; range: 0-90.4). No significant differences in median proportion of noisy voxels were observed between examinations performed at 1.5 T and those at 3 T (P = 0.89 before and after adjustment). No clinical or technical factors significantly influenced the proportion of noisy voxels., Conclusion: Two-dimensional real time multislice MR-thermometry is feasible and accurate for monitoring prostate temperature in patients., Competing Interests: Declaration of competing interest P.B and T.F are employed by Certis therapeutics V.O and B.Q are co-founders and scientific advisors of Certis Therapeutics. The others authors have no relevant financial or non-financial interests to disclose in relation with this article., (Copyright © 2024. Published by Elsevier Masson SAS.)